Analyst Ratings for Retension Pharmaceuticals (RTSN)
RTSN Rating Summary
RTSN Price Target Summary
- Highest: $55.00 (Guggenheim)
- Lowest: $50.00 (Oppenheimer)
- Average: $51.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$51.67 (+338.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Avg. $ Target:
$51.67 (+338.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/3/2026 | Leerink | Roanna Ruiz | New Coverage | Outperform (N/A) |
50.00 (N/A) |
11.30 (11.79) |
4.34% | Details |
| 11/3/2026 | Oppenheimer | Jay Olson | New Coverage | Outperform (N/A) |
50.00 (N/A) |
11.30 (11.79) |
4.34% | Details |
 |
||||||||
